# Golimumab for Adherence in Rheumatoid Arthritis

> **NCT03729349** · — · COMPLETED · sponsor: **Janssen Inc.** · enrollment: 222 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **BIOLOGICAL:** Golimumab

## Key facts

- **NCT ID:** NCT03729349
- **Lead sponsor:** Janssen Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-15
- **Primary completion:** 2023-06-19
- **Final completion:** 2023-06-19
- **Target enrollment:** 222 (ACTUAL)
- **Last updated:** 2024-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03729349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03729349, "Golimumab for Adherence in Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03729349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*